These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36034864)

  • 21. Relaxin induces up-regulation of ADAM10 metalloprotease in RXFP1-expressing cells by PI3K/AKT signaling.
    Boccalini G; Sassoli C; Bani D; Nistri S
    Mol Cell Endocrinol; 2018 Sep; 472():80-86. PubMed ID: 29180109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties.
    Beiert T; Knappe V; Tiyerili V; Stöckigt F; Effelsberg V; Linhart M; Steinmetz M; Klein S; Schierwagen R; Trebicka J; Roell W; Nickenig G; Schrickel JW; Andrié RP
    Int J Cardiol; 2018 Jan; 250():21-28. PubMed ID: 29169754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relaxin and maternal lactocrine programming of neonatal uterine development.
    Bartol FF; Wiley AA; Bagnell CA
    Ann N Y Acad Sci; 2009 Apr; 1160():158-63. PubMed ID: 19416179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered expression of RXFP1 receptor contributes to the inefficacy of relaxin-based anti-fibrotic treatments in systemic sclerosis.
    Corallo C; Pinto AM; Renieri A; Cheleschi S; Fioravanti A; Cutolo M; Soldano S; Nuti R; Giordano N
    Clin Exp Rheumatol; 2019; 37 Suppl 119(4):69-75. PubMed ID: 31365333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The chemically synthesized human relaxin-2 analog, B-R13/17K H2, is an RXFP1 antagonist.
    Hossain MA; Samuel CS; Binder C; Hewitson TD; Tregear GW; Wade JD; Bathgate RA
    Amino Acids; 2010 Jul; 39(2):409-16. PubMed ID: 20043231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of the novel bioluminescent ligand-receptor binding assay to relaxin-RXFP1 system for interaction studies.
    Wu QP; Zhang L; Shao XX; Wang JH; Gao Y; Xu ZG; Liu YL; Guo ZY
    Amino Acids; 2016 Apr; 48(4):1099-1107. PubMed ID: 26767372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged RXFP1 and RXFP2 signaling can be explained by poor internalization and a lack of beta-arrestin recruitment.
    Callander GE; Thomas WG; Bathgate RA
    Am J Physiol Cell Physiol; 2009 May; 296(5):C1058-66. PubMed ID: 19279230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relaxin receptor as a therapeutic target - perspectives from evolution and drug targeting.
    Bathgate RAD; Kocan M; Scott DJ; Hossain MA; Good SV; Yegorov S; Bogerd J; Gooley PR
    Pharmacol Ther; 2018 Jul; 187():114-132. PubMed ID: 29458108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of RXFP1 in skin of scleroderma patients and control subjects.
    Giordano N; Volpi N; Franci D; Corallo C; Fioravanti A; Papakostas P; Montella A; Biagioli M; Fimiani M; Grasso G; Muscettola MM; Guerranti R; Vannoni D; Galeazzi M; Nuti R
    Scand J Rheumatol; 2012 Oct; 41(5):391-5. PubMed ID: 23043266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis.
    Ho TY; Santora K; Chen JC; Frankshun AL; Bagnell CA
    Bone; 2011 Jun; 48(6):1346-53. PubMed ID: 21419242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290.
    Huang Z; Myhr C; Bathgate RA; Ho BA; Bueno A; Hu X; Xiao J; Southall N; Barnaeva E; Agoulnik IU; Marugan JJ; Ferrer M; Agoulnik AI
    Front Endocrinol (Lausanne); 2015; 6():128. PubMed ID: 26347712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-β/Smad3 signaling.
    Sassoli C; Chellini F; Pini A; Tani A; Nistri S; Nosi D; Zecchi-Orlandini S; Bani D; Formigli L
    PLoS One; 2013; 8(5):e63896. PubMed ID: 23704950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relaxin receptor (RXFP1) utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activation.
    Kong RC; Petrie EJ; Mohanty B; Ling J; Lee JC; Gooley PR; Bathgate RA
    J Biol Chem; 2013 Sep; 288(39):28138-51. PubMed ID: 23926099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relaxin (RLX) and estrogen affect estrogen receptor alpha, vascular endothelial growth factor, and RLX receptor expression in the neonatal porcine uterus and cervix.
    Yan W; Chen J; Wiley AA; Crean-Harris BD; Bartol FF; Bagnell CA
    Reproduction; 2008 May; 135(5):705-12. PubMed ID: 18304981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2.
    Scott DJ; Rosengren KJ; Bathgate RA
    Mol Endocrinol; 2012 Nov; 26(11):1896-906. PubMed ID: 22973049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1.
    Wilhelmi T; Xu X; Tan X; Hulshoff MS; Maamari S; Sossalla S; Zeisberg M; Zeisberg EM
    Theranostics; 2020; 10(9):3905-3924. PubMed ID: 32226528
    [No Abstract]   [Full Text] [Related]  

  • 37. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
    Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ
    Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relaxin family peptide receptor 1 (RXFP1): An emerging player in human health and disease.
    Chen TY; Li X; Hung CH; Bahudhanapati H; Tan J; Kass DJ; Zhang Y
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1194. PubMed ID: 32100955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimally invasive, sustained-release relaxin-2 microparticles reverse arthrofibrosis.
    Kirsch JR; Williamson AK; Yeritsyan D; Blessing WA; Momenzadeh K; Leach TR; Williamson PM; Korunes-Miller JT; DeAngelis JP; Zurakowski D; Nazarian RM; Rodriguez EK; Nazarian A; Grinstaff MW
    Sci Transl Med; 2022 Oct; 14(666):eabo3357. PubMed ID: 36223449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relaxin family peptide receptor (RXFP1) coupling to G(alpha)i3 involves the C-terminal Arg752 and localization within membrane Raft Microdomains.
    Halls ML; van der Westhuizen ET; Wade JD; Evans BA; Bathgate RA; Summers RJ
    Mol Pharmacol; 2009 Feb; 75(2):415-28. PubMed ID: 19029286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.